Joost A.P. Rens
Pharmaleads (France)(FR)UCB Pharma (Netherlands)(NL)
Publications by Year
Research Areas
Estrogen and related hormone effects, HER2/EGFR in Cancer Research, Cancer Immunotherapy and Biomarkers, Angiogenesis and VEGF in Cancer, Cell Adhesion Molecules Research
Most-Cited Works
- → Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition(2011)342 cited
- → Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα–CD47 innate immune checkpoint(2019)66 cited
- → Differential effects of matrix and growth factors on endothelial and fibroblast motility: Application of a modified cell migration assay(2006)61 cited
- → Differential TIMP3 expression affects tumor progression and angiogenesis in melanomas through regulation of directionally persistent endothelial cell migration(2013)41 cited
- → Discovery of Targets for Immune–Metabolic Antitumor Drugs Identifies Estrogen-Related Receptor Alpha(2023)37 cited
- → Targeting melanoma with immunoliposomes coupled to anti-MAGE A1 TCR-like single-chain antibody(2016)35 cited
- → PDGF-Induced Migration of Vascular Smooth Muscle Cells Is Inhibited by Heme Oxygenase-1 Via VEGFR2 Upregulation and Subsequent Assembly of Inactive VEGFR2/PDGFRβ Heterodimers(2012)33 cited
- → Tissue inhibitor of metalloproteinase-3 (TIMP3) expression decreases during melanoma progression and inhibits melanoma cell migration(2016)31 cited
- → E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cells(2012)28 cited
- → EMAP-II facilitates TNF-R1 apoptotic signalling in endothelial cells and induces TRADD mobilization(2006)19 cited